<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Global IP Watch - Intellectual Property for International Professionals &#187; double patenting</title>
	<atom:link href="http://www.globalipwatch.com/tag/double-patenting/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.globalipwatch.com</link>
	<description>Intellectual Property for International Professionals</description>
	<lastBuildDate>Wed, 04 Jan 2012 03:06:37 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>FC Finds Anticipated Formulation Patent Non-Obvious Since Same Prior Art Would Teach Away From Invention</title>
		<link>http://www.globalipwatch.com/2010/07/01/fc-finds-anticipated-formulation-patent-non-obvious-since-same-prior-art-would-teach-away-from-invention/</link>
		<comments>http://www.globalipwatch.com/2010/07/01/fc-finds-anticipated-formulation-patent-non-obvious-since-same-prior-art-would-teach-away-from-invention/#comments</comments>
		<pubDate>Thu, 01 Jul 2010 18:21:49 +0000</pubDate>
		<dc:creator>Inder Gida</dc:creator>
				<category><![CDATA[Canada: Patents]]></category>
		<category><![CDATA[anticipation]]></category>
		<category><![CDATA[double patenting]]></category>
		<category><![CDATA[NOC]]></category>
		<category><![CDATA[obviousness]]></category>
		<category><![CDATA[Swiss claims]]></category>
		<category><![CDATA[teaching away]]></category>

		<guid isPermaLink="false">http://www.globalipwatch.com/?p=1437</guid>
		<description><![CDATA[In Merck &#38; Co. Inc. v. Pharmascience Inc. (2010 FC 510), the Federal Court (FC) dismissed Merck &#38; Co. Inc.&#8217;s (Merck) application to prohibit the Minister of Health from issuing a Notice of Compliance (NOC) to Pharmascience Inc. The FC found Canadian Patent No. 2,173,457 (the &#8217;457 patent) invalid on the basis of double patenting [...]]]></description>
		<wfw:commentRss>http://www.globalipwatch.com/2010/07/01/fc-finds-anticipated-formulation-patent-non-obvious-since-same-prior-art-would-teach-away-from-invention/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

